ahlam1399
07-01-2016, 03:23 PM
AstraZeneca sells two dermatology drug rights to LEO Pharma
(Reuters) - British drugmaker AstraZeneca Plc said it sold the rights to develop an experimental mid-stage drug to treat atopic dermatitis to privately-held LEO Pharma.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=ccqKsvHDY-I:6BG0InklPDk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ccqKsvHDY-I:6BG0InklPDk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=ccqKsvHDY-I:6BG0InklPDk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ccqKsvHDY-I:6BG0InklPDk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=ccqKsvHDY-I:6BG0InklPDk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/ccqKsvHDY-I
(Reuters) - British drugmaker AstraZeneca Plc said it sold the rights to develop an experimental mid-stage drug to treat atopic dermatitis to privately-held LEO Pharma.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=ccqKsvHDY-I:6BG0InklPDk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ccqKsvHDY-I:6BG0InklPDk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=ccqKsvHDY-I:6BG0InklPDk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=ccqKsvHDY-I:6BG0InklPDk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=ccqKsvHDY-I:6BG0InklPDk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/ccqKsvHDY-I